feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Smartwatches to Predict Cancer Risk for NHS Patients

Smartwatches to Predict Cancer Risk for NHS Patients

5 Feb

•

Summary

  • NHS patients to receive real-time cancer risk insights.
  • Wearable tech data to be integrated with medical records.
  • Multi-cancer early detection tests to be piloted by NHS.
Smartwatches to Predict Cancer Risk for NHS Patients

Within the next decade, NHS patients will have access to real-time, personalized insights regarding their cancer risk. This national plan involves combining information from medical records, DNA analysis, demographic data, and lifestyle habits with data from clinically validated wearable technology such as smartwatches. The NHS app will serve as a central 'dashboard for cancer prevention,' providing users with advice on habits to reduce their risk.

Furthermore, the plan aims to integrate tests capable of detecting multiple cancers before symptoms appear into NHS screening programs. These early detection blood tests, like those being piloted in the Galleri trial, have the potential to significantly transform diagnosis and allow for earlier treatment. By 2035, all cancer patients will have the option for comprehensive genomic analysis.

The initiative is part of a broader strategy to improve cancer survival rates in the UK. Health minister Wes Streeting, who has personal experience with cancer, is championing this

trending

Cognizant profit rises 18.7%

trending

HAL shares tumble after AMCA

trending

Bharat Taxi launches in Delhi

trending

JSW Cement Q3 profit rises

trending

Qualcomm stock falls on shortages

trending

MHADA lottery 2026 delayed

trending

Trent share price cautious outlook

trending

Pakistan India T20 boycott

trending

Thunder versus Spurs preview

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The NHS plans to use data from clinically validated wearables like smartwatches to assess activity levels and other fitness data that influences cancer risk, integrating it with medical records for personalized insights.
The goal is to provide everyone with access to real-time, personalized cancer risk insights within a decade, encouraging lifestyle changes and enabling earlier detection through integrated data and new screening tests.
Yes, tests that can detect multiple cancers before symptoms appear are being piloted, with the ambition to incorporate them into national screening programs if proven effective and safe.

Read more news on

Healthside-arrow

You may also like

UK Cancer Care Crisis: Staff Cuts Threaten Patient Treatment

13 hours ago • 5 reads

article image

NHS Cancer Targets: A Race Against Time

19 hours ago • 7 reads

article image

Cervical Cancer Tests Go Home: Easier Access Ahead

1 hour ago

article image

Brits Flunking Fibre: 96% Fall Short

2 Feb • 13 reads

article image

NHS England Lowers Bowel Cancer Test Threshold

26 Jan • 57 reads

article image